272 related articles for article (PubMed ID: 21531813)
1. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
[TBL] [Abstract][Full Text] [Related]
4. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.
Segelman J; Singnomklao T; Hellborg H; Martling A
Colorectal Dis; 2009 Sep; 11(7):768-74. PubMed ID: 18662241
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
[TBL] [Abstract][Full Text] [Related]
6. Gene signature is associated with early stage rectal cancer recurrence.
Kalady MF; Dejulius K; Church JM; Lavery IC; Fazio VW; Ishwaran H
J Am Coll Surg; 2010 Aug; 211(2):187-95. PubMed ID: 20670856
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in colorectal cancer patients.
Laohavinij S; Maneechavakajorn J; Techatanol P
J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
[TBL] [Abstract][Full Text] [Related]
8. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
11. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer.
Huang MY; Wang JY; Chang HJ; Kuo CW; Tok TS; Lin SR
Oncol Rep; 2011 May; 25(5):1297-306. PubMed ID: 21344162
[TBL] [Abstract][Full Text] [Related]
12. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.
Korsgaard M; Pedersen L; Sørensen HT; Laurberg S
Colorectal Dis; 2006 Oct; 8(8):688-95. PubMed ID: 16970580
[TBL] [Abstract][Full Text] [Related]
13. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
14. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
15. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
16. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
18. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer.
Vermeulen PB; Van den Eynden GG; Huget P; Goovaerts G; Weyler J; Lardon F; Van Marck E; Hubens G; Dirix LY
Br J Cancer; 1999 Jan; 79(2):316-22. PubMed ID: 9888475
[TBL] [Abstract][Full Text] [Related]
20. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
